Combined Research Orlando Phase I-IV /ID# 247697 — Orlando, Florida

Combined Research Orlando Phase I-IV /ID# 247697 is a clinical research site located in Orlando, Florida, United States 32814.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Combined Research Orlando Phase I-IV /ID# 247697 has participated in 1 clinical trials.

Therapeutic areas: Alzheimer's Disease (AD).

Sponsors: AbbVie.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Combined Research Orlando Phase I-IV /ID# 247697?

Combined Research Orlando Phase I-IV /ID# 247697 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Combined Research Orlando Phase I-IV /ID# 247697 conducted?

Combined Research Orlando Phase I-IV /ID# 247697 has 1 clinical trials on record. Their work covers Alzheimer's Disease (AD).

Is Combined Research Orlando Phase I-IV /ID# 247697 accredited by Crixeo Health?

Combined Research Orlando Phase I-IV /ID# 247697 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Combined Research Orlando Phase I-IV /ID# 247697?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.